To further determine the selectivity of the treatment on the growth of wildtype and CTDNEP1-deficient tumor cells, we treated control or CTDNEP1-knockdown D283 or MB-004 cells with JQ1 and prexasertib. This evidence concerns the gene CTDNEP1 and neoplasm.